Morning nasal congestion can signal allergies, sinusitis, dry air, GERD, or structural nasal issues. ENT experts say that ...
One of the biggest concerns with upper respiratory tract infections, like the common cold or a nasal infection, is the ...
It's one of the most common nasal complaints and while often harmless, it can be maddening and affect sleep, focus and even ...
Paris Jackson, 27, shared with her TikTok followers that her past drug use has taken a toll on her nasal tissues. She held up ...
Congestion - that bunged up, stuffy nose feeling - is usually a fleeting symptom of a cold which lasts for around a week and ...
ACAAI: Sanofi and Regeneron’s Dupixent pivotal study met all primary and secondary endpoints, reducing signs and symptoms of allergic fungal rhinosinusitis; sBLA accepted for FDA priority review Phase ...
Sanofi & Regeneron’s Dupixent pivotal study meets all primary and secondary endpoints, reducing signs and symptoms of allergic fungal rhinosinusitis: Paris Monday, November 10, ...
Adult patients with severe CRSwNP treated with tezepelumab continued to receive benefit 24 weeks after treatment cessation.
Sanofi and Regeneron Pharmaceuticals said their jointly developed Dupixent anti-inflammatory blockbuster drug achieved primary and secondary goals in a late-stage study for allergic fungal ...
Regeneron and Sanofi’s Dupixent trial shows major improvement in allergic fungal rhinosinusitis symptoms in patients 6+. Read ...
Phase 3 data to be presented at ACAAI demonstrate Dupixent significantly reduced key nasal signs and symptoms including sinus opacification, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback